Biallelic mutations in the IGHMBP2 have been associated with two distinct phenotypes: spinal muscular atrophy with respiratory distress type 1 (SMARD1) and CMT2S. We describe a patient who developed progressive muscle weakness and wasting in her upper and lower limbs from infancy. She developed respiratory involvement at age 9, eventually requiring 24-h non-invasive ventilation, and severe autonomic dysfunction restricted to the gastrointestinal tract. Neurophysiological studies at age 27 years revealed absent sensory and motor responses and severe chronic denervation changes in proximal muscles of the upper limbs. Targeted multigene panel sequencing detected a novel homozygous missense variant in the IGHMBP2 gene (c.1325A > G; p.Tyr442Cys). This variant was validated by Sanger sequencing and co-segregation analysis confirmed that both parents were asymptomatic heterozygous carriers. This case report confirms that IGHMBP2 related disorders can result in a severe peripheral neuropathy with gastrointestinal autonomic dysfunction requiring parenteral nutrition.

IGHMBP2 mutation associated with organ-specific autonomic dysfunction / P.J. Tomaselli, A. Horga, A.M. Rossor, Z. Jaunmuktane, A. Cortese, J.C. Blake, N. Zarate-Lopez, H. Houlden, M.M. Reilly. - In: NEUROMUSCULAR DISORDERS. - ISSN 0960-8966. - 28:12(2018 Dec), pp. 1012-1015. [10.1016/j.nmd.2018.08.010]

IGHMBP2 mutation associated with organ-specific autonomic dysfunction

A. Cortese;
2018

Abstract

Biallelic mutations in the IGHMBP2 have been associated with two distinct phenotypes: spinal muscular atrophy with respiratory distress type 1 (SMARD1) and CMT2S. We describe a patient who developed progressive muscle weakness and wasting in her upper and lower limbs from infancy. She developed respiratory involvement at age 9, eventually requiring 24-h non-invasive ventilation, and severe autonomic dysfunction restricted to the gastrointestinal tract. Neurophysiological studies at age 27 years revealed absent sensory and motor responses and severe chronic denervation changes in proximal muscles of the upper limbs. Targeted multigene panel sequencing detected a novel homozygous missense variant in the IGHMBP2 gene (c.1325A > G; p.Tyr442Cys). This variant was validated by Sanger sequencing and co-segregation analysis confirmed that both parents were asymptomatic heterozygous carriers. This case report confirms that IGHMBP2 related disorders can result in a severe peripheral neuropathy with gastrointestinal autonomic dysfunction requiring parenteral nutrition.
CMT; IGHMBP2 gene; Next generation sequencing; SMARD1; Target multigene panel; Adult; Autonomic Nervous System Diseases; DNA Mutational Analysis; DNA-Binding Proteins; Female; High-Throughput Nucleotide Sequencing; Humans; Muscle Weakness; Muscle; Skeletal; Neural Conduction; Transcription Factors; Mutation; Missense
Settore MEDS-01/A - Genetica medica
Settore MEDS-12/A - Neurologia
dic-2018
https://www.sciencedirect.com/science/article/pii/S096089661731550X?via=ihub
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS096089661731550X.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1241139
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 19
  • OpenAlex ND
social impact